ALTANA AG: Extraordinary General Meeting approves sale of pharmaceuticals business

21-Dec-2006 - The shareholders of ALTANA AG approved the sale of ALTANA Pharma to Nycomed at the Extraordinary General Meeting in Frankfurt. In his speech, Dr. Nikolaus Schweickart, President and CEO of ALTANA AG, explained to the shareholders the main reasons for the sale of the pharmaceuticals business and ...

ALTANA obtains approval by antitrust authorities for sale of its pharmaceuticals business

15-Dec-2006 - ALTANA AG has announced that the European and U.S. antitrust authorities have approved the acquisition of ALTANA's pharmaceuticals business by Nycomed without conditions. ALTANA AG announced the sale of ALTANA Pharma AG and its entire pharmaceuticals business to Nycomed on September 21, 2006. ...

ALTANA AG: Sale of pharmaceuticals business to Nycomed

Purchase price of approx. EUR4.5 billion

22-Sep-2006 - ALTANA AG announced the sale of ALTANA Pharma AG and its entire pharmaceuticals business to Nycomed. The Supervisory Board of ALTANA AG has approved this transaction. The completion of the transaction is subject to approval by the competent antitrust authorities in the EU and the U.S. It is also ...

ALTANA opens pharmaceutical production facility in Ireland

11-Jul-2006 - ALTANA Pharma performed the official opening of a new tablet production facility in Cork (Ireland) in the presence of the Irish Prime Minister, Mr. Bertie Ahern. The new plant will play an important role in ALTANA Pharma's global production network and provide extended capacity for the ...

Altana Pharma invests in new High Throughput Screening system from Thermo Electron

18-Nov-2005 - Thermo Electron Corporation announced that it had secured a major contract with Altana Pharma to install a fully integrated Ultra High Throughput Screening system. Named last year as one of the most profitable pharmaceutical operations in Europe, Altana focuses on identifying new therapeutic ...

First European market launch of Alvesco

Altana Pharma launches Alvesco in the United Kingdom, Launch in Germany imminent

19-Jan-2005 - Altana AG has announced that Alvesco® (Ciclesonide), a novel inhaled corticosteroid (ICS) for the treatment of adults (18+ years) suffering from persistent asthma is now available for the first time in the United Kingdom (UK). Altana Pharma also received the national marketing license for Germany ...

ALTANA opens Research Institute in the U.S.

16-Jun-2003 - ALTANA Pharma AG, Constance, the pharmaceutical division of ALTANA AG, Bad Homburg, officially opened the ALTANA Research Institute (ARI) in Waltham, Boston (USA). Having spent several months building up a research organization and reconstructing the facility, the research center is now ready to ...

Cork Planning Application from ALTANA Pharma

27-May-2003 - ALTANA Pharma AG, the international research-based pharmaceutical group with headquarters in Germany, is set to lodge a formal planning application for its proposed production facility at the IDA Industrial Estate, Carrigtwohill, Co. Cork. This EUR70 million investment in a high-value tablet ...

ALTANA divests parts of its diagnostics business

02-Dec-2002 - ALTANA Pharma AG, Constance, is to sell substantial parts of its in-vitro diagnostics business to its alliance partner, DiaSorin S.r.l. of Sallugia in Italy. The sale will go ahead with effect from December 31 subject to approval by the appropriate cartel authorities. "This sale is consistent ...